ANMCO Position paper in collaboration with ITACARE-P : Anti-ischemic treatment in patients with chronic coronary syndrome
Over the last decade, pharmacological therapies for primary and secondary prevention of chronic coronary syndromes enriched with new agents have been demonstrated to be effective in reducing cardiovascular adverse events. However, currently available evidence on treatment for anginal symptom control is weaker. This position paper of the Italian Association of Hospital Cardiologists (ANMCO) aims to briefly report evidence that supports the use of anti-ischemic drugs for chronic coronary syndromes. Furthermore, we propose a therapeutic algorithm for the choice of the most appropriate drug on the basis of the clinical characteristics of the individual patient.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Giornale italiano di cardiologia (2006) - 24(2023), 7 vom: 10. Juli, Seite 571-580 |
| Sprache: |
Italienisch |
|---|
| Weiterer Titel: |
Position paper ANMCO in collaborazione con ITACARE-P: Terapia anti-ischemica nei pazienti con sindrome coronarica cronica |
|---|
| Beteiligte Personen: |
Riccio, Carmine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.07.2023 Date Revised 03.07.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1714/4060.40436 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358933641 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358933641 | ||
| 003 | DE-627 | ||
| 005 | 20231226075809.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||ita c | ||
| 024 | 7 | |a 10.1714/4060.40436 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1196.xml |
| 035 | |a (DE-627)NLM358933641 | ||
| 035 | |a (NLM)37392122 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Riccio, Carmine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ANMCO Position paper in collaboration with ITACARE-P |b Anti-ischemic treatment in patients with chronic coronary syndrome |
| 246 | 3 | 3 | |a Position paper ANMCO in collaborazione con ITACARE-P: Terapia anti-ischemica nei pazienti con sindrome coronarica cronica |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.07.2023 | ||
| 500 | |a Date Revised 03.07.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Over the last decade, pharmacological therapies for primary and secondary prevention of chronic coronary syndromes enriched with new agents have been demonstrated to be effective in reducing cardiovascular adverse events. However, currently available evidence on treatment for anginal symptom control is weaker. This position paper of the Italian Association of Hospital Cardiologists (ANMCO) aims to briefly report evidence that supports the use of anti-ischemic drugs for chronic coronary syndromes. Furthermore, we propose a therapeutic algorithm for the choice of the most appropriate drug on the basis of the clinical characteristics of the individual patient | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Mureddu, Gian Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Di Fusco, Stefania Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Abrignani, Maurizio Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Orso, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Temporelli, Pier Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a De Luca, Leonardo |e verfasserin |4 aut | |
| 700 | 1 | |a Fattirolli, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Faggiano, Pompilio |e verfasserin |4 aut | |
| 700 | 1 | |a Ambrosetti, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Nardi, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Caldarola, Pasquale |e verfasserin |4 aut | |
| 700 | 1 | |a Gulizia, Michele Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Gabrielli, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Oliva, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Colivicchi, Furio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Giornale italiano di cardiologia (2006) |d 2006 |g 24(2023), 7 vom: 10. Juli, Seite 571-580 |w (DE-627)NLM16119561X |x 1972-6481 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:7 |g day:10 |g month:07 |g pages:571-580 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1714/4060.40436 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 7 |b 10 |c 07 |h 571-580 | ||